Biotechnology and IP Archives

Non-obviousness of Biotech Inventions in USA

First Publication Date: 26th December 2010. The Non-obviousness standards required for biotechnology inventions have been interpreted by courts to be different from the generally accepted principles. In Hybritech v. Monoclonal , a case involving a patent over "Immunometric Assays Using Monoclonal Antibodies", the court held the patent non-obvious despite the existence of twenty prior art references because the prior art as a whole did not make the invention obvious at the time the invention was made. Though some references seemed to…

December 28, 2018 BananaIP Reporter Intellectual Property 0Comment 1080Views 0Like

ShareFacebook

The image depicts a person in a laboratory.

Patentability of Biotech Inventions in USA – Patentable Subject Matter

First Publication Date: 27th December 2010 To be patentable subject matter in USA, an invention should be a process, machine, manufacture or composition of matter or any improvement thereof. There are three judicially created exclusions to patentable subject matter in USA. They are Laws of nature, physical phenomena, and abstract ideas. Biotechnology (Biotech) inventions are considered to be eligible subjects as Compositions of matter or manufactures. The exclusion most relevant for biotech inventions is 'Laws of nature' exclusion. US Courts…

December 27, 2018 BananaIP Reporter Intellectual Property, Patents 0Comment 3593Views 0Like

ShareFacebook

This image depicts a DNA strand. The DNA forms the basis of all life forma and conquering it is the challenge for biotechnology. This post is about the patentability of biotech inventions. Click on the image to read the full post.

Biotechnology and Patent Challenge

First Publication Date: 19th December 2010 Since its inception, patent law has been customized and fine-tuned by governments to meet the needs of evolving technologies. Strong basic principles have evolved to cater to the needs of traditional fields of science and technology, and they have been working well in promoting progress. However, these basic principles have utterly failed in a number of ways when applied to Modern Biotechnology. The unique nature of Modern Biotechnology is the main reason for this failure. Why…

December 25, 2018 BananaIP Reporter Intellectual Property, Patents 0Comment 1053Views 0Like

ShareFacebook

The image depicts the cover of the presentation with title of Trade Secrets and Biotechnology by Dr. Kalyan C Kankanala

Small Business Innovative Research Initiative (SBIRI) Scheme from Department of Biotechnology

First Publication Date: 24th December 2009. Department of Biotechnology has introduced a scheme to fund projects of small business innovative research Initiative. The scheme has become immensely popular as almost 56 Successful SBIRI applicants are listed for the scheme as on 26/11/2009. The aim of the scheme is to encourage small and medium scale industries to take up risk in innovative R&D in biotech sector. The intellectual property generated from the Project shall be the joint property of the Industry…

October 28, 2018 BananaIP Reporter Intellectual Property, Patents 0Comment 975Views 0Like

ShareFacebook

Biotechnology Industry Partnership Programme (BIPP), New Scheme from Department of Biotechnology for Advanced Technology Science

Biotechnology Industry Partnership Programme (BIPP) is a new partnership programme with industries for support on a cost-sharing basis for high-risk discovery and innovation, accelerated technology development especially for futuristic areas like transformational technology and product development for the public good, areas having major economic potential with focused on IP creation with ownerships by Indian industry, development of technologies in the area of agriculture, health, bio-energy, green manufacturing etc. The objective is to assist and promote emerging biotech entrepreneurs and facilitate innovative…